Atul (500027) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
25 Aug, 2025Executive summary
Unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024, were reviewed and approved by the Board on January 24, 2025.
Statutory auditors issued unmodified limited review reports for both standalone and consolidated results.
Financial highlights
Standalone revenue from operations for Q3 FY25 was ₹1,273.71 cr, up from ₹1,106.17 cr in Q3 FY24; consolidated revenue was ₹1,416.83 cr, up from ₹1,137.80 cr year-over-year.
Standalone net profit for Q3 FY25 was ₹92.66 cr, compared to ₹109.76 cr in Q3 FY24; consolidated net profit was ₹117.10 cr, up from ₹72.05 cr year-over-year.
For the nine months ended December 31, 2024, standalone revenue was ₹3,759.90 cr (vs ₹3,246.18 cr), and consolidated revenue was ₹4,131.71 cr (vs ₹3,513.53 cr) year-over-year.
Standalone EPS for Q3 FY25 was ₹31.47 (basic and diluted); consolidated EPS was ₹36.93 (basic and diluted).
Total comprehensive income for Q3 FY25 was ₹44.59 cr (standalone) and ₹64.41 cr (consolidated).
Outlook and guidance
No forward-looking guidance or outlook was provided in the disclosed results.
Latest events from Atul
- Q3 FY26 consolidated net profit rose to ₹163.54 crore on revenue of ₹1,573.62 crore.500027
Q3 25/2623 Jan 2026 - Strong revenue and profit growth in H1 FY2025, led by core chemical segments.500027
Q2 25/2617 Oct 2025 - Strong revenue and profit growth driven by robust segment performance and clean audit review.500027
Q1 24/2525 Aug 2025 - Q2 FY25 saw strong revenue and profit growth, led by chemicals segments and robust margins.500027
Q2 24/2525 Aug 2025 - Revenue and profit rose, dividend of ₹25/share proposed, and new Secretarial Auditors appointed.500027
Q4 24/2525 Aug 2025 - Consolidated revenue and profit rose year-over-year, led by strong chemical segment growth.500027
Q1 25/2625 Aug 2025